Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 256 to 270 of 537 results for syndrome

  1. Constipation in children and young people: diagnosis and management (CG99)

    This guideline covers diagnosing and managing constipation in children and young people up to 18. It provides strategies to support the early identification and timely, effective treatment of constipation which will help improve outcomes for patients. It does not cover constipation caused by a specific condition.

  2. FreeO2 automatic oxygen titration for chronic obstructive pulmonary disease and respiratory distress syndrome (MIB281)

    NICE has developed a medtech innovation briefing (MIB) on FreeO2 automatic oxygen titration for chronic obstructive pulmonary disease and respiratory distress syndrome .

  3. Social anxiety disorder: recognition, assessment and treatment (CG159)

    This guideline covers recognising, assessing and treating social anxiety disorder (also known as ‘social phobia’) in children and young people (from school age to 17 years) and adults (aged 18 years and older). It aims to improve symptoms, educational, occupational and social functioning, and quality of life in people with social anxiety disorder.

  4. Care and support of people growing older with learning disabilities (NG96)

    This guideline covers care and support for adults with learning disabilities as they grow older. It covers identifying changing needs, planning for the future, and delivering services including health, social care and housing. It aims to support people to access the services they need as they get older.

  5. Dietary strategies: What is the clinical and cost effectiveness of dietary strategies in managing ME/CFS?

    guidance Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management Number NG206 Date issued

  6. Sleep management strategies: What is the clinical and cost effectiveness of sleep management strategies in managing ME/CFS?

    guidance Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management Number NG206 Date issued

  7. Diagnostic criteria: In people with suspected ME/CFS, how effective is the NICE 2021 consensus-based diagnostic criteria in identifying people with ME/CFS?

    guidance Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management Number NG206 Date issued

  8. Self-monitoring management strategies: What is the clinical and cost effectiveness of self-monitoring strategies and techniques in guiding energy management?

    guidance Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management Number NG206 Date issued

  9. A core outcome set: What core set of relevant health outcome measures should be used for trials of treatments for ME/CFS and managing symptoms of ME/CFS?

    guidance Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management Number NG206 Date issued

  10. Bile acid malabsorption: colesevelam (ESUOM22)

    Summary of the evidence on colesevelam for treating bile acid malabsorption (BAM) to inform local NHS planning and decision-making

  11. Percutaneous insertion of a catheter-based left ventricular microaxial flow pump for cardiogenic shock (HTG775)

    Evidence-based recommendations on percutaneous insertion of a catheter-based left ventricular microaxial flow pump for cardiogenic shock. This involves a small pump being inserted through the skin, through an artery and into the heart, to temporarily pump blood out of the heart and restore blood flow.

  12. Surgical insertion of a catheter-based left ventricular microaxial flow pump for cardiogenic shock (HTG774)

    Evidence-based recommendations on surgical insertion of a catheter-based left ventricular microaxial flow pump for cardiogenic shock. This involves a small pump being surgically inserted using a graft, through an artery and into the heart, to temporarily pump blood out of the heart and restore blood flow.

  13. Eating disorders: recognition and treatment (NG69)

    This guideline covers assessment, treatment, monitoring and inpatient care for children, young people and adults with eating disorders. It aims to improve the care people receive by detailing the most effective treatments for anorexia nervosa, binge eating disorder and bulimia nervosa.

  14. COVID-19 rapid guideline: managing COVID-19 (NG191)

    This guideline covers managing COVID-19 in babies, children, young people and adults in community and hospital settings. It includes recommendations on communication, assessment, therapeutics for COVID-19, non-invasive respiratory support, preventing and managing acute complications, and identifying and managing co-infections.

  15. Constipation in children and young people (QS62)

    This quality standard covers the diagnosis and management of constipation of unknown cause in babies, children and young people (from birth to 18 years). It describes high-quality care in priority areas for improvement.